Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20
about
Platinum-induced hearing loss after treatment for childhood cancerProposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA)Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancerCanadian consensus guidelines for the management of testicular germ cell cancer.Testicular cancer survivorship: research strategies and recommendations.Quality of life among testicular cancer survivors: a case-control study in the United StatesAccelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapyFeasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer.Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).Genetic variants associated with cisplatin-induced ototoxicity.Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.Update on management of seminoma.Complications associated with chemotherapy in testicular cancer management.Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy.Development and validation of a cisplatin dose-ototoxicity model.Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.Long-term toxicity of cisplatin in germ-cell tumor survivors.Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up?Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.
P2860
Q26470526-24D905F2-EED2-4E35-9542-300C1AE03BDEQ27342479-F55CB1FC-6BAD-4BB0-9193-9D45D28D2AEEQ28261683-542714B9-20DD-4C64-9BE4-727794A25680Q33403094-E136E4D3-1FB1-469F-91B6-00C8987A2BF5Q33660380-95EFAC78-60A2-4868-8C07-6A4B0BB68D16Q33753786-3CD33B5F-75EB-413A-B09B-93D33211102BQ34039684-56AC630F-B172-4825-9558-5BB9A69BE4F9Q35146293-8D2DA3AD-6A5A-46C8-B486-958A4BBAA06EQ35208183-B449E80F-FC2C-403C-B585-8145B5D18BFEQ35721076-31839727-6EAC-468E-8995-005CF2992B41Q36166130-12181652-6DD9-4621-A96D-0C9AE4ABB9DEQ36406771-0DC55E3D-682E-4D51-99F0-41D5558CA6FDQ36616067-A9EFB918-56BC-4521-A5EC-ADE479F2600DQ37293994-50AFD0BE-480D-4348-93F0-A7FE2B42278BQ37478015-C151203A-EBF0-416C-BA2B-3CAFFD29D55AQ37763853-4ADC8EB8-6D61-4A54-BC43-289110E4B1B7Q37853021-C41EFA14-AF8F-4590-8DC5-80821663A94AQ39885004-DC0E8266-CEF8-47C6-A70B-4FA4688F1532Q40610815-87B39BCA-D92A-4CFE-9619-8B2C4E231D59Q41322086-20ADAD66-1DED-4A9D-91A6-D00DDC9D3C52Q41504828-BE4A7028-3147-4611-9001-0BE0C8C34A1FQ46952443-A7B31C3B-1895-4CCC-80DA-915FFDF49798Q47239998-12581750-3076-4620-AC26-58027748C4C6Q50464252-4A1ABEF8-1124-410C-B3FF-A4B9023F9957Q50464497-187F35AB-D5C1-4A7C-A89B-AD993CDCFD7AQ51374798-01BFD799-45E5-4B51-A865-8835B4D7500EQ55162138-ABF8887E-D6D8-4253-8B8B-0928B3124703
P2860
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Quality of life in good progno ...... Cancer Study Group (30941/TE20
@en
Quality of life in good progno ...... Testicular Cancer Study Group
@nl
type
label
Quality of life in good progno ...... Cancer Study Group (30941/TE20
@en
Quality of life in good progno ...... Testicular Cancer Study Group
@nl
prefLabel
Quality of life in good progno ...... Cancer Study Group (30941/TE20
@en
Quality of life in good progno ...... Testicular Cancer Study Group
@nl
P2093
P356
P1476
Quality of life in good progno ...... Cancer Study Group (30941/TE20
@en
P2093
European Organization for Research and Treatment of Cancer Genitourinary Group 30941
Graham M Mead
J Trevor Roberts
Laurence Collette
Linda de Prijck
Medical Research Council Testicular Cancer Study Group TE20
Neil K Aaronson
Peter M Wilkinson
Pieter H M de Mulder
P304
P356
10.1200/JCO.2003.02.075
P407
P577
2003-03-01T00:00:00Z